Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo.
Schistosomiasis is second only to malaria as the most devastating parasitic disease in the world. It is caused by the helminths Schistosoma mansoni (S. mansoni), S. haematobium, or S. japonicum. Typically, patients with schistosomiasis suffer from symptoms of liver fibrosis and hepatosplenomegaly. C...
Main Authors: | Ho Yin Pekkle Lam, Ting-Ruei Liang, Shih-Yi Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-06-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0009554 |
Similar Items
-
Salmonella typhimurium exacerbates injuries but resolves fibrosis in liver and spleen during Schistosoma mansoni infection
by: Ho Yin Pekkle Lam, et al.
Published: (2023-06-01) -
Albendazole-Schisandrin B Co-Therapy on <i>Angiostrongylus cantonensis</i>-Induced Meningoencephalitis in Mice
by: Ho Yin Pekkle Lam, et al.
Published: (2020-07-01) -
Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice
by: Ho Yin Pekkle Lam, et al.
Published: (2022-04-01) -
The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production
by: Chun-Ming Chang, et al.
Published: (2024-01-01) -
Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
by: Mohamed A Dkhi
Published: (2014-01-01)